David Colker

Business Reporter, Los Angeles Times

Host

Business reporter for the Los Angeles Times

David Colker on KCRW

This may be the last Christmas for Bratz dolls and a lot of jobs in Van Nuys.

Barbie Beats the Bratz

This may be the last Christmas for Bratz dolls and a lot of jobs in Van Nuys.

from Which Way, L.A.?

Barbie dolls are worth approximately three billion dollars a year to Mattel, based in El Segundo.

Barbie Versus Bratz

Barbie dolls are worth approximately three billion dollars a year to Mattel, based in El Segundo.

from Which Way, L.A.?

More from KCRW

The cannabis industry entered 2021 on a high note. Did that optimism hold through the year and what can we expect in 2022?

from KCRW Features

The Biden administration is offering four free antigen COVID tests to each household in the U.S., and signups open today. Test results are available within 30 minutes.

from KCRW Features

Cutting or eliminating greenhouse gas emissions is the aim of two new developments in Valencia and Tejon Ranch.

from Greater LA

Kroger grocery workers are experiencing widespread food insecurity, wage disparity, and harsh working conditions, according to a new report by Economic Roundtable.

from KCRW Features

Following Saturday’s hostage situation in Texas, LA rabbi Steve Leder shares why local places of worship prioritize security training.

from Press Play with Madeleine Brand

A new nature preserve in the Tehachapi Mountains and Southern Sierra Nevada aims to become a sanctuary for California’s iconic species to adjust to climate change.

from KCRW Features

Marine Mammal Care Center LA has survived struggles and the pandemic as it cares for injured sea life. Now the center has reopened to the public.

from Greater LA

California is losing its leadership position in the effort to mitigate climate change, and politics and other disasters may be to blame, according to a state lawmaker.

from To the Point

We may need additional booster shots down the line, but for now the fully vaccinated are well protected against Omicron, according to Dr. Michael Wilkes of UC Davis.

from KCRW Features